BASILE, Vittoria
 Distribuzione geografica
Continente #
EU - Europa 3.709
NA - Nord America 1.566
AS - Asia 535
SA - Sud America 53
AF - Africa 40
OC - Oceania 39
Continente sconosciuto - Info sul continente non disponibili 4
Totale 5.946
Nazione #
IT - Italia 2.246
US - Stati Uniti d'America 1.491
FR - Francia 857
CN - Cina 194
DE - Germania 106
GB - Regno Unito 90
JP - Giappone 63
IN - India 61
RU - Federazione Russa 58
CA - Canada 57
CZ - Repubblica Ceca 45
ES - Italia 44
VN - Vietnam 42
AU - Australia 35
PL - Polonia 34
GR - Grecia 30
CH - Svizzera 27
HK - Hong Kong 25
BR - Brasile 24
TR - Turchia 23
PT - Portogallo 21
IE - Irlanda 20
NL - Olanda 19
KR - Corea 18
MX - Messico 17
IR - Iran 16
BE - Belgio 15
PK - Pakistan 15
IL - Israele 14
ZA - Sudafrica 14
RO - Romania 13
SE - Svezia 13
TW - Taiwan 13
CL - Cile 11
UA - Ucraina 11
AR - Argentina 9
SG - Singapore 9
SI - Slovenia 9
ET - Etiopia 8
HU - Ungheria 8
PH - Filippine 8
SA - Arabia Saudita 8
DZ - Algeria 7
DK - Danimarca 6
FI - Finlandia 6
LT - Lituania 6
CO - Colombia 5
LY - Libia 5
MK - Macedonia 5
AE - Emirati Arabi Uniti 4
BG - Bulgaria 4
NZ - Nuova Zelanda 4
YE - Yemen 4
AL - Albania 3
EC - Ecuador 3
EU - Europa 3
HR - Croazia 3
MD - Moldavia 3
TH - Thailandia 3
AT - Austria 2
BA - Bosnia-Erzegovina 2
EG - Egitto 2
IQ - Iraq 2
JO - Giordania 2
LB - Libano 2
SY - Repubblica araba siriana 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BD - Bangladesh 1
BF - Burkina Faso 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
GH - Ghana 1
ID - Indonesia 1
KZ - Kazakistan 1
LV - Lettonia 1
MA - Marocco 1
MO - Macao, regione amministrativa speciale della Cina 1
MY - Malesia 1
NO - Norvegia 1
PE - Perù 1
PS - Palestinian Territory 1
UG - Uganda 1
Totale 5.946
Città #
Fairfield 127
Houston 124
Santa Cruz 100
Torino 90
Woodbridge 87
Seattle 84
Rome 78
Ann Arbor 76
Buffalo 71
Ashburn 67
Milan 60
Cambridge 59
Wilmington 44
Dong Ket 31
Beijing 30
Genova 30
Florence 29
Turin 28
Napoli 24
Shanghai 22
Palermo 21
Pisa 21
Bengaluru 19
Bologna 18
Brescia 18
Dublin 18
Naples 17
Rochester 17
Athens 16
San Diego 16
Senigallia 15
Wuhan 15
Chicago 14
Changsha 13
Ottawa 13
Arezzo 12
Hangzhou 12
Tokyo 12
Würzburg 12
Cecina 11
Los Angeles 11
Paris 11
Redmond 11
Shenyang 11
Cagliari 10
Dallas 10
Guangzhou 10
Lonate Ceppino 10
Mountain View 10
Munich 10
Taipei 10
University Park 10
Chengdu 9
Nanjing 9
Padova 9
A Coruña 8
Freiburg 8
Hyderabad 8
Milpitas 8
Muizenberg 8
Portland 8
Sydney 8
Toronto 8
Warsaw 8
Amsterdam 7
Boardman 7
Bradford 7
Central 7
Chieti 7
Council Bluffs 7
Memphis 7
New York 7
Québec 7
Boves 6
Budapest 6
Chennai 6
Cincinnati 6
Delhi 6
Forlì 6
Helsinki 6
Henderson 6
Las Vegas 6
Mumbai 6
Porto 6
Taranto 6
Tehran 6
Trento 6
Venice 6
Zurich 6
Alaşehir 5
Birmingham 5
Boulder 5
Brussels 5
Castelnuovo Di Porto 5
Cavarzere 5
Charleston 5
Charlestown 5
Chiyoda-ku 5
Clearwater 5
Dearborn 5
Totale 2.008
Nome #
Diagnosi e terapia del carcinoma corticosurrenalico, file e27ce429-8a4b-2581-e053-d805fe0acbaa 2.111
New perspectives for mitotane treatment of adrenocortical carcinoma, file e27ce431-2a78-2581-e053-d805fe0acbaa 762
SEX DIFFERENCES ON MITOTANE CONCENTRATION AND TREATMENT OUTCOME IN PATIENTS WITH ADRENOCORTICAL CARCINOMA, file e27ce431-ddf4-2581-e053-d805fe0acbaa 598
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients, file e27ce42f-5a62-2581-e053-d805fe0acbaa 477
Decision-making for adrenocortical carcinoma: surgical, systemic, and endocrine management options., file e27ce42d-a4bd-2581-e053-d805fe0acbaa 302
Gender-based evaluation of the effect of mitotane on total cholesterol, HDL, LDL and triglycerides levels in patients with adrenocortical carcinoma, file bc58b4c0-d211-4567-a298-33d9469bb163 262
Treatment with 90Y/177Lu DOTATOC in patients with metastatic adrenocortical carcinoma expressing somatostatin receptors, file e27ce42f-7222-2581-e053-d805fe0acbaa 253
18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma., file e27ce428-d302-2581-e053-d805fe0acbaa 199
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma, file e27ce42c-70ef-2581-e053-d805fe0acbaa 132
Gender-based evaluation of the effect of mitotane on total cholesterol, HDL, LDL and triglycerides levels in patients with adrenocortical carcinoma, file 6230cd5b-b82f-4394-916c-496a213cf767 119
Mitotane: new facts for an old drug, file e27ce42e-ace4-2581-e053-d805fe0acbaa 106
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane., file e27ce42a-1a58-2581-e053-d805fe0acbaa 101
Expression of SOAT1 in Adrenocortical Carcinoma and Response to Mitotane Monotherapy: An ENSAT Multicenter Study, file e27ce42f-b58d-2581-e053-d805fe0acbaa 99
Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study, file e27ce431-4984-2581-e053-d805fe0acbaa 98
Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment, file e27ce42e-f005-2581-e053-d805fe0acbaa 90
Mitotane concentrations influence outcome in patients with advanced adrenocortical carcinoma, file e27ce42f-bc48-2581-e053-d805fe0acbaa 90
Involvement of 27-Hydroxycholesterol in Mitotane Action on Adrenocortical Carcinoma, file e27ce42f-e1cd-2581-e053-d805fe0acbaa 76
Unwanted hormonal and metabolic effects of postoperative adjuvant mitotane treatment for adrenocortical cancer, file e27ce431-42ac-2581-e053-d805fe0acbaa 57
Sex Differences on Mitotane Concentration and Treatment Outcome in Patients with Adrenocortical Carcinoma, file e27ce431-615f-2581-e053-d805fe0acbaa 52
What is the optimal duration of adjuvant mitotane therapy in adrenocortical carcinoma? An unanswered question, file e27ce432-246d-2581-e053-d805fe0acbaa 39
Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence., file e27ce433-fabc-2581-e053-d805fe0acbaa 22
Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence., file e27ce42e-ce06-2581-e053-d805fe0acbaa 11
Sex differences on mitotane concentration and treatment outcome in patients with adrenocortical carcinoma, file 2b1a2a94-ae71-42dc-b83e-849198b18acb 9
Pregnancy in patients with adrenocortical carcinoma: a case-based discussion, file d34b5ff3-b205-4255-bbc5-3f22e2213b56 9
Effects of mitotane on the hypothalamic-pituitary-adrenal axis in patients with adrenocortical carcinoma, file 46675b6e-6c0b-445b-bf84-7164b823926a 7
Sex-Based Evaluation of Lipid Profile in Postoperative Adjuvant Mitotane Treatment for Adrenocortical Carcinoma, file f50fd863-420d-4151-8d79-a9a350494107 6
Influence of the CYP2B6 polymorphism on the pharmacokinetics of mitotane., file e27ce426-e4db-2581-e053-d805fe0acbaa 4
Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study, file de252e95-f3bf-495c-b371-7775bcd1226c 3
18F-FDG PET/CT in the post-operative monitoring of patients with adrenocortical carcinoma., file e27ce42e-8fb8-2581-e053-d805fe0acbaa 2
The Value of Local Therapies in Advanced Adrenocortical Carcinoma, file 9a7d4910-ae9b-40c7-be34-7295d061d256 1
Totale 6.097
Categoria #
all - tutte 7.754
article - articoli 0
book - libri 0
conference - conferenze 772
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.526


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019119 0 0 0 0 0 0 0 0 0 39 46 34
2019/2020524 25 25 22 36 25 18 33 68 75 65 66 66
2020/2021950 77 88 97 70 73 74 63 65 60 79 99 105
2021/20221.239 115 74 83 159 148 66 90 89 69 79 174 93
2022/2023927 46 64 141 101 85 102 80 75 80 90 52 11
2023/2024858 12 4 11 12 9 7 379 395 21 8 0 0
Totale 6.097